← Back to Clinical Trials
Recruiting NCT06806488
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
Trial Parameters
Condition Marginal Zone B Cell Lymphoma
Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study Type OBSERVATIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-05
Completion 2025-10
Brief Summary
This is a purely retrospective and observational monocentric study
Eligibility Criteria
Inclusion Criteria: 1. Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018. 2. Age ≥ 18 years at enrolment. 3. Written informed consent (if applicable) Exclusion Criteria: * none